Rapid diagnosis of candidiasis and aspergillosis

Insights

Detecting fungal antigens in severe candidiasis patients shows promise. Stable Candida and Aspergillus antigens are detectable in blood, though detection methods need improvement for better sensitivity.

Area of Science:

  • Mycology
  • Clinical Microbiology
  • Immunodiagnostics

Background:

  • Severe candidiasis involves bloodstream infections by Candida species.
  • Circulating fungal antigens are potential biomarkers for invasive fungal infections.
  • Previous studies suggest the presence of both stable and labile antigens in candidiasis.

Purpose of the Study:

  • To evaluate the presence and detectability of circulating fungal antigens in patients with severe candidiasis.
  • To assess the characteristics of stable and labile antigens from Candida albicans and Candida tropicalis.
  • To explore the utility of antigen detection for diagnosing invasive aspergillosis.

Main Methods:

  • Analysis of patient sera for fungal antigens using dissociation techniques.
  • Characterization of antigen stability (stable vs. labile) and antibody binding.
  • Quantification of antigen concentrations in the nanogram-per-milliliter range.

Main Results:

  • Two types of circulating antigens (stable and labile) were supported in severe candidiasis.
  • Stable antigens required dissociation from antibodies for detection.
  • Dissociation destroyed labile antigens, complicating assessment of antibody-bound forms.
  • Similar dissociation steps were needed for Aspergillus fumigatus antigen detection.
  • Stable antigen concentrations were in the nanogram-per-milliliter range, near assay detection limits.

Conclusions:

  • Circulating stable antigens of Candida and Aspergillus are detectable in patients with invasive infections.
  • Current detection assays for these fungal antigens have limitations in sensitivity and practicality.
  • Further improvements in diagnostic assays are needed, but antigen detection shows diagnostic potential.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...